From the carrier of active substance to drug delivery systems | Zendy

Barbara Jadach | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

From the carrier of active substance to drug delivery systems

Author(s) -

Barbara Jadach

Publication year - 2017

Publication title -

journal of medical science

Language(s) - English

Resource type - Journals

eISSN - 2353-9801

pISSN - 2353-9798

DOI - 10.20883/jms.2017.198

Subject(s) - drug delivery , drug , active ingredient , bioavailability , site of action , biocompatible material , pharmaceutical sciences , nanotechnology , dosage form , drug carrier , patient compliance , biochemical engineering , risk analysis (engineering) , pharmacology , business , materials science , medicine , biomedical engineering , engineering , emergency medicine

Development and innovation all the time are in interests of pharmaceutical science and evaluation of different dosage forms. They are concerned with the aim of compliance of patients. All the time different research groups try to develop and improve form of drugs to receive better bioavailability or strict control of dose, place and time of action of active substances. This is possible by using different excipients; biodegradable, biocompatible polymers that work like a carriers; developing simple drug delivery systems, which in time became more and more complicated; nanotechnology that control size, shape and multi-functionality of particulate drug delivery systems. This review shows the main points in the evaluation of pharmaceutical researches from simple carriers of active substances to drug delivery systems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research